616402 TACE Substrate II, Fluorogenic
Recommended Products
Přehled
Replacement Information |
---|
References | |
---|---|
References | Patel, I.R., et al. 1998. J. Immunol. 160, 4570. Van Dyk, D.E., et al. 1997. Bioorg. Med. Chem. Lett. 7, 1219. |
Product Information | |
---|---|
Form | Liquid |
Formulation | A 4 mM (7.5 mg/ml) solution in DMSO. |
Hill Formula | C₆₉H₁₀₃N₂₃O₂₄ |
Chemical formula | C₆₉H₁₀₃N₂₃O₂₄ |
Applications |
---|
Biological Information | |
---|---|
Purity | ≥90% by HPLC |
Physicochemical Information | |
---|---|
Peptide Sequence | MCA-Pro-Leu-Ala-Gln-Ala-Val-Dpa-Arg-Ser-Ser-Ser-Arg-NH₂[Dpa = N-3-(2,4-Dinitrophenyl)-L-2,3-diaminopropionyl] |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Katalogové číslo | GTIN |
616402 | 0 |
Documentation
TACE Substrate II, Fluorogenic Certificates of Analysis
Title | Lot Number |
---|---|
616402 |
References
Přehled odkazů |
---|
Patel, I.R., et al. 1998. J. Immunol. 160, 4570. Van Dyk, D.E., et al. 1997. Bioorg. Med. Chem. Lett. 7, 1219. |